A Ten-Year Analysis of Receptor Variability and Phenotypic Changes in Metastatic Breast Cancer: Insights from a Retrospective Study of 363 Cases at a Single Institution - Top-Institutions - MDSpire

A Ten-Year Analysis of Receptor Variability and Phenotypic Changes in Metastatic Breast Cancer: Insights from a Retrospective Study of 363 Cases at a Single Institution

  • By

  • Sijie Chen

  • Qianqian Sun

  • Li Yan

  • Jiao Yang

  • Jin Yang

  • April 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Molecular Pathology
    • Translational Cancer Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Research
    • Molecular Oncology
    • Clinical Trials

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Medical Oncology
    • Cancer Genomics
    • Pathology

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Breast Cancer Pathology
    • Molecular Diagnostics
    • Clinical Oncology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Breast Cancer Research
    • Molecular Pathology
    • Precision Oncology

Original Source(s)

A Ten-Year Analysis of Receptor Variability and Phenotypic Changes in Metastatic Breast Cancer: Insights from a Retrospective Study of 363 Cases at a Single Institution

  • by Sijie Chen, Qianqian Sun, Li Yan, Jiao Yang, Jin Yang

  • April 20, 2026

Related Content

Insulin-like growth factor 1 receptor regulates breast cancer cell adhesion through beta-1 integrin

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min
Predicting preoperative axillary lymph node metastasis to guide surgical decisions in invasive breast cancer